# Tricida, Inc.: Form D filings

Tricida, Inc., a pharmaceuticals company in South San Francisco, CA, filed 4 Form D notices with the SEC between 2014 and 2017. The latest, on November 15, 2017, reports $57.6 million sold of a $57.6 million offering to 13 investors.

Find out what Tricida, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Tricida%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Tricida%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ftricida-inc-1595585)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Tricida%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Tricida%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ftricida-inc-1595585)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 7000 SHORELINE COURT, SUITE 201, South San Francisco, CA, 94080
- Phone: (415) 429-7800
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2013
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1595585

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 15, 2017 | New notice | $57,559,996 | $57,559,996 | $0 | 13 | Nov 7, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1595585/000159558517000001/0001595585-17-000001-index.htm) |
| Jul 25, 2016 | New notice | $55,500,000 | $23,908,857 | $31,591,143 | 6 | Jul 12, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1595585/000159558516000003/0001595585-16-000003-index.htm) |
| Feb 27, 2015 | New notice | $30,250,000 | $17,141,667 | $13,108,333 | 4 | Feb 13, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1595585/000161836415000001/0001618364-15-000001-index.htm) |
| Jan 30, 2014 | New notice | $13,164,243 | $4,514,244 | $8,649,999 | 3 | Dec 18, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1595585/000159558514000002/0001595585-14-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Edward Hejlek | Executive Officer |  |
| Klaus Veitinger | Director |  |
| Gerrit Klaerner | Executive Officer, Director |  |
| David Hirsch | Director |  |
| Jerry Buysse | Executive Officer |  |
| Robert Alpern | Director |  |
| Sandra Coufal | Director |  |
| David Bonita | Director |  |
| Wilhelm Stahl | Executive Officer |  |
| Claire Lockey | Executive Officer |  |
| Geoffrey Parker | Executive Officer |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Nov 13, 2017](https://specstream.ai/data/form-d/week/2017-11-13) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Tricida, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).